ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 74 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $316,000 | +75.6% | 59,771 | +59.4% | 0.00% | – |
| Q1 2021 | $180,000 | +14.6% | 37,492 | +3.7% | 0.00% | – |
| Q4 2020 | $157,000 | -35.4% | 36,150 | -38.7% | 0.00% | – |
| Q3 2020 | $243,000 | +60.9% | 58,990 | +0.0% | 0.00% | – |
| Q2 2020 | $151,000 | -11.2% | 58,963 | 0.0% | 0.00% | – |
| Q1 2020 | $170,000 | -23.8% | 58,963 | 0.0% | 0.00% | – |
| Q4 2019 | $223,000 | -68.6% | 58,963 | -57.5% | 0.00% | -100.0% |
| Q3 2019 | $710,000 | -17.4% | 138,724 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $860,000 | -53.8% | 138,724 | -41.6% | 0.00% | 0.0% |
| Q1 2019 | $1,862,000 | +79.6% | 237,478 | +95.5% | 0.00% | 0.0% |
| Q4 2018 | $1,037,000 | -56.2% | 121,459 | +2.8% | 0.00% | -66.7% |
| Q3 2018 | $2,365,000 | -37.4% | 118,117 | -19.2% | 0.00% | -40.0% |
| Q2 2018 | $3,775,000 | +333.4% | 146,129 | +301.1% | 0.01% | +400.0% |
| Q1 2018 | $871,000 | -29.5% | 36,431 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $1,235,000 | +59.8% | 36,431 | -0.2% | 0.00% | +100.0% |
| Q3 2017 | $773,000 | – | 36,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|